Fix the ALS Clinical Trial System
I AM ALS commits to bringing together all parts of the ALS community in a patient-driven effort to identify strategies to address existing issues in clinical trials and deliver progress against ALS. In order to meet this moment, there are systemic issues we must address by bringing together patients and caregivers, organizations, biopharmaceutical companies, researchers, clinicians and FDA, NIH and Congressional leaders.
We commit to partner with the entire ALS community to create the clinical trial system patients deserve — one that most efficiently and urgently delivers effective treatments and cures. If you have issues that should be addressed or ideas for how to improve the clinical trial system for ALS, please share them in the form provided.